Healthcare -
Biotechnology - NASDAQ - US
$ 0.7817
0.786 %
$ 42.6 M
Market Cap
9.77
P/E
SPRO - CASH FROM OPERATIONS
Cash from Operations SPRO - Spero Therapeutics, Inc.
-33 M
LAST VALUE
28.39%
2 YEAR CAGR
3.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR